Patient centricity

Safety and value driving Phase IV growth at CROs; EVP

Safety and value driving Phase IV growth at CROs; EVP

By Gareth Macdonald

Increased focus on post-market safety and value has resulted in CROs handling more Phase IV work, according to a PharmaNet EVP, and this trend may continue as regulators seek real world evidence.

Follow us

Products

View more

Webinars